Stromal Fibroblast Autophagy In Tumor Progression and Desmoplasia

肿瘤进展和结缔组织形成中的基质成纤维细胞自噬

基本信息

项目摘要

PROJECT SUMMARY Carcinoma progression depends on the interactions of epithelial tumor cells with their surrounding stroma. Fibroblasts represent a principal component of this stroma, which modulates tumor cell behavior through diverse mechanisms, including the synthesis of growth and angiogenic factors, cytokines, extracellular matrix components and proteases. Indeed, many solid tumors exhibit striking histological evidence of fibroblast proliferation and activation, termed desmoplasia. Although desmoplasia in human cancers tightly correlates with poor prognosis, the molecular mechanisms that generate and maintain this desmoplastic response remain unknown. In preliminary studies, we have uncovered that autophagy in stromal fibroblasts is crucial for promoting both desmoplasia and tumor progression. Autophagy is a tightly regulated lysosomal degradation process that promotes tumor cell survival and metabolic adaptation. There is great interest in targeting autophagy against cancer due to its well-established effects on tumor cell survival; however, the potential pro- tumorigenic functions of autophagy in the host stroma remain unknown. We hypothesize that autophagy in stromal fibroblasts is critical to initiate and maintain a desmoplastic fibrotic response and to facilitate tumor progression. Using powerful immune-competent mammary cancer models and tools uniquely developed in our laboratory, we will rigorously scrutinize the functions of stromal fibroblast autophagy during cancer progression in vivo. In Aim 1, we will determine how autophagy in stromal fibroblasts modulates tissue stiffness and ECM remodeling. In Aim 2, we will dissect how autophagy-dependent secretion by stromal fibroblasts promotes carcinoma progression and influences the tumor microenvironment. In Aim 3, we will corroborate the effects of stromal fibroblast autophagy in mammary cancer progression and metastasis using autochthonous tumor models. These studies will provide unique conceptual insight into whether and how the autophagy pathway in host fibroblasts can be modulated to abolish the stromal response required for cancer progression.
项目概要 癌症进展取决于上皮肿瘤细胞与其周围基质的相互作用。 成纤维细胞是该基质的主要成分,它通过以下方式调节肿瘤细胞的行为: 多种机制,包括生长和血管生成因子、细胞因子、细胞外基质的合成 成分和蛋白酶。事实上,许多实体瘤表现出成纤维细胞的惊人组织学证据 增殖和激活,称为结缔组织增生。尽管人类癌症中的结缔组织增生与 如果预后不良,产生和维持这种促纤维增生反应的分子机制仍然存在 未知。在初步研究中,我们发现基质成纤维细胞中的自噬对于 促进结缔组织增生和肿瘤进展。自噬是一种严格调控的溶酶体降解 促进肿瘤细胞存活和代谢适应的过程。对目标有很大兴趣 自噬对抗癌症,因为其对肿瘤细胞存活的明确影响;然而,潜在的亲 宿主基质中自噬的致瘤功能仍不清楚。我们假设自噬 基质成纤维细胞对于启动和维持促结缔组织增生性纤维化反应以及促进肿瘤生长至关重要 进展。使用我们独特开发的强大的免疫能力乳腺癌模型和工具 实验室,我们将严格审查基质成纤维细胞自噬在癌症进展过程中的功能 体内。在目标 1 中,我们将确定基质成纤维细胞中的自噬如何调节组织硬度和 ECM 重塑。在目标 2 中,我们将剖析基质成纤维细胞的自噬依赖性分泌如何促进 癌症进展并影响肿瘤微环境。在目标 3 中,我们将验证以下效果: 使用原生肿瘤进行乳腺癌进展和转移中的基质成纤维细胞自噬 模型。这些研究将为自噬途径是否以及如何参与提供独特的概念见解。 可以调节宿主成纤维​​细胞以消除癌症进展所需的基质反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jayanta Debnath其他文献

Jayanta Debnath的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jayanta Debnath', 18)}}的其他基金

Autophagy-dependent exosome loading and biogenesis in AD and FTD
AD 和 FTD 中自噬依赖性外泌体负载和生物发生
  • 批准号:
    9919472
  • 财政年份:
    2017
  • 资助金额:
    $ 32.89万
  • 项目类别:
Autophagy-dependent exosome loading and biogenesis in AD and FTD
AD 和 FTD 中自噬依赖性外泌体负载和生物发生
  • 批准号:
    10176326
  • 财政年份:
    2017
  • 资助金额:
    $ 32.89万
  • 项目类别:
Endolysosomal defects in secretory autophagy and microglial toxicity in FTD
FTD 中分泌性自噬和小胶质细胞毒性的内溶酶体缺陷
  • 批准号:
    10623233
  • 财政年份:
    2017
  • 资助金额:
    $ 32.89万
  • 项目类别:
Stromal Fibroblast Autophagy In Tumor Progression and Desmoplasia
肿瘤进展和结缔组织形成中的基质成纤维细胞自噬
  • 批准号:
    10295179
  • 财政年份:
    2017
  • 资助金额:
    $ 32.89万
  • 项目类别:
Stromal Fibroblast Autophagy In Tumor Progression and Desmoplasia
肿瘤进展和结缔组织形成中的基质成纤维细胞自噬
  • 批准号:
    10058245
  • 财政年份:
    2017
  • 资助金额:
    $ 32.89万
  • 项目类别:
Deciphering Autophagy-Dependent Secretion In Cancer Via Proximity-Based Biotinylation
通过基于邻近的生物素化破译癌症中自噬依赖性分泌
  • 批准号:
    9178012
  • 财政年份:
    2016
  • 资助金额:
    $ 32.89万
  • 项目类别:
Autophagy and Epithelial Cell Fate During Anoikis and 3D Morphogenesis
失巢凋亡和 3D 形态发生过程中的自噬和上皮细胞命运
  • 批准号:
    7808677
  • 财政年份:
    2009
  • 资助金额:
    $ 32.89万
  • 项目类别:
Autophagy and Epithelial Cell Fate During Anoikis and 3D Morphogenesis
失巢凋亡和 3D 形态发生过程中的自噬和上皮细胞命运
  • 批准号:
    8211075
  • 财政年份:
    2009
  • 资助金额:
    $ 32.89万
  • 项目类别:
Autophagy and Pro-metastatic Differentiation
自噬和促转移分化
  • 批准号:
    10307119
  • 财政年份:
    2009
  • 资助金额:
    $ 32.89万
  • 项目类别:
Autophagy and Epithelial Cell Fate During Anoikis and 3D Morphogenesis
失巢凋亡和 3D 形态发生过程中的自噬和上皮细胞命运
  • 批准号:
    8071994
  • 财政年份:
    2009
  • 资助金额:
    $ 32.89万
  • 项目类别:

相似海外基金

How angiogenic factor induces immunosuppressive cells to tumor microenvironment
血管生成因子如何诱导免疫抑制细胞进入肿瘤微环境
  • 批准号:
    22KJ0818
  • 财政年份:
    2023
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10711027
  • 财政年份:
    2021
  • 资助金额:
    $ 32.89万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10297199
  • 财政年份:
    2021
  • 资助金额:
    $ 32.89万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10625314
  • 财政年份:
    2021
  • 资助金额:
    $ 32.89万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10405070
  • 财政年份:
    2021
  • 资助金额:
    $ 32.89万
  • 项目类别:
Physiological role of anti-angiogenic factor thrombospondin in the regulation of endometrial function during early pregnancy in cattle
抗血管生成因子血小板反应蛋白在牛妊娠早期子宫内膜功能调节中的生理作用
  • 批准号:
    20K06385
  • 财政年份:
    2020
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of lymphangiogenic regulatory mechanism of angiogenic factor CCN2 through tumor-associated macrophage
阐明血管生成因子CCN2通过肿瘤相关巨噬细胞的淋巴管生成调节机制
  • 批准号:
    17K11866
  • 财政年份:
    2017
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of vascular stabilization mechanism by anti-angiogenic factor vasohibin-1
抗血管生成因子 vasohibin-1 阐明血管稳定机制
  • 批准号:
    15K20874
  • 财政年份:
    2015
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
  • 批准号:
    15K15523
  • 财政年份:
    2015
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The development of the anti-angiogenic factor VEGF-A165b quantification methods for cardiovascular disease.
心血管疾病抗血管生成因子 VEGF-A165b 定量方法的开发。
  • 批准号:
    26860367
  • 财政年份:
    2014
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了